E
Evolent Health, Inc. EVH
$2.99 -$0.07-2.29% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Evolent Health, Inc. is a healthcare services and technology company focused on enabling value-based care delivery in the U.S. healthcare market. The company operates at the intersection of healthcare providers and health plans, offering clinical, administrative, and technology solutions designed to improve health outcomes while controlling medical costs. Evolent primarily serves physician organizations, health systems, and payers that participate in risk-based and value-based reimbursement models.

Founded in 2011, Evolent Health evolved from a provider-centric care management platform into a broader healthcare services organization with both provider-facing and payer-facing capabilities. Its core revenue drivers include care management services, specialty management, administrative services, and proprietary healthcare technology platforms. The company is positioned as a partner that enables complex population health management, particularly for patients with chronic and specialty conditions, and differentiates itself through scale, data analytics, and experience managing downside risk arrangements.

Business Operations

Evolent Health reports operations across two primary business segments: Technology and Services (T&S) and Evolent Care Partners (ECP). The Technology and Services segment delivers administrative services, care management, specialty benefit management, and clinical workflow solutions primarily to health plans and provider organizations, generating recurring service-based revenue. The Evolent Care Partners segment focuses on value-based arrangements where Evolent participates in shared savings or downside risk with provider partners, making revenue more variable and tied to medical cost performance.

Operations are predominantly domestic, with the majority of revenue generated in the United States healthcare market. The company controls proprietary clinical and administrative platforms, population health analytics, and utilization management technologies. Evolent operates through several subsidiaries, including New Century Health, which provides specialty care management services in oncology, cardiology, and musculoskeletal care. The company also maintains offshore technology and operational support functions, primarily for software development and analytics.

Strategic Position & Investments

Evolent Health’s strategic direction emphasizes scaling its payer-facing services, expanding specialty care management, and reducing exposure to volatile full-risk provider arrangements. In recent years, the company has shifted capital allocation toward higher-margin, more predictable service-based offerings, while selectively exiting or restructuring underperforming risk-based contracts within Evolent Care Partners.

Key investments include the continued integration and expansion of New Century Health and related specialty management capabilities, which represent a strategic growth engine aligned with rising specialty drug and procedure costs. Evolent has also invested in automation, artificial intelligence-enabled analytics, and clinical decision support tools to enhance medical cost management. Where outcomes or asset performance have been mixed, the company has publicly acknowledged portfolio rationalization efforts; in some cases, the long-term financial impact remains data inconclusive based on available public sources.

Geographic Footprint

Evolent Health is headquartered in Arlington, Virginia, and operates primarily across the United States, serving national and regional health plans, provider networks, and physician groups. Its market presence spans multiple states, with particularly strong penetration in large, diversified healthcare markets where value-based care adoption is more advanced.

International operations are limited and primarily support-oriented rather than revenue-generating. The company maintains technology, analytics, and operational support teams in India, which contribute to software development and back-office functions. Evolent does not report significant direct healthcare delivery or payer operations outside the U.S., and its international exposure is not considered a core strategic growth driver.

Leadership & Governance

Evolent Health was co-founded by Frank Williams, who previously served as Chief Executive Officer and remains actively involved in governance. The current leadership team emphasizes disciplined growth, operational focus, and a strategic shift toward scalable, repeatable healthcare services. Management has articulated a vision centered on being a leading enablement partner for value-based specialty and population health management.

Key executives include:

  • Seth Blackley – Chief Executive Officer
  • Frank Williams – Executive Chairman
  • John Johnson – Chief Financial Officer
  • Chris Michalik – President and Chief Operating Officer
  • Matthew Garber – Chief Development Officer

The leadership team collectively brings experience across healthcare services, payer operations, and provider-led care models, with governance structures aligned to public company and regulated healthcare market requirements.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $180.25
B
AAPL NASDAQ $250.12
B
MSFT NASDAQ $395.55
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.52
B
Top Financial Stocks
See All »
B
B
JPM NYSE $283.44
B
V NYSE $307.14
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.08
Top Health Care Stocks
See All »
B
LLY NYSE $985.08
B
JNJ NYSE $241.52
B
AMGN NASDAQ $366.21
Top Real Estate Stocks
See All »
B
PLD NYSE $131.75